Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
Athanassios Fragoulis,
Julia Schenkel,
Nicole Schröder,
Elisa Fabiana Brandt,
Mathias Weiand,
Tabita Neu,
Pierluigi Ramadori,
Tim Caspers,
Sebastian Kant,
Thomas Pufe,
Antje Mohs,
Christian Trautwein,
Thomas Longerich,
Konrad Ludwig Streetz,
Christoph Jan Wruck
Affiliations
Athanassios Fragoulis
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany
Julia Schenkel
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany
Nicole Schröder
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany
Elisa Fabiana Brandt
Department of Medicine III, Uniklinik RWTH Aachen, Germany
Mathias Weiand
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany
Tabita Neu
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany
Pierluigi Ramadori
Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
Tim Caspers
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany
Sebastian Kant
Institute of Molecular and Cellular Anatomy, Uniklinik RWTH Aachen, Germany
Thomas Pufe
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany
Antje Mohs
Department of Medicine III, Uniklinik RWTH Aachen, Germany
Christian Trautwein
Department of Medicine III, Uniklinik RWTH Aachen, Germany
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg, Germany
Konrad Ludwig Streetz
Department of Medicine III, Uniklinik RWTH Aachen, Germany
Christoph Jan Wruck
Department of Anatomy and Cell Biology, Uniklinik RWTH Aachen, Germany; Corresponding author. Department of Anatomy and Cell Biology; Medical Faculty; Uniklinik RWTH Aachen; Wendlingweg 2, 52074, Aachen, Germany.
The Nrf2 signaling pathway prevents cancer initiation, but genetic mutations that activate this pathway are found in various types of cancer. The molecular mechanisms underlying this Janus-headed character are still not understood. Here, we show that sustained Nrf2 activation induces proliferation and dedifferentiation of a Wnt-responsive perivenular hepatic progenitor cell population, transforming them into metastatic cancer cells. The neoplastic lesions display many histological features known from human hepatoblastoma. We describe an Nrf2-induced upregulation of β-catenin expression and its activation as the underlying mechanism for the observed malignant transformation. Thus, we have identified the Nrf2–β-catenin axis promoting proliferation of hepatic stem cells and triggering tumorigenesis. These findings support the concept that different functional levels of Nrf2 control both the protection against various toxins as well as liver regeneration by activating hepatic stem cells. Activation of the hepatic stem cell compartment confers the observation that unbridled Nrf2 activation may trigger tumorigenesis.